Skip to main content

CITIGROUP INC

Position in ERAS — Erasca, Inc.

CIK 831001 NEW YORK, NY

Position in ERAS

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$13,071,942
+$12,277,344 QoQ
Shares Held
713,534
+1352.9% QoQ
Ownership
0.204%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#52
of 257 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ERAS Over Time

Shares Held

Position Value (USD)

Derivatives in ERAS

reported options exposure · as of Jun 30, 2026
CallValue
$732,800
CallShares
40,000
PutValue
$732,800
PutShares
40,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. ERAS ranks #30 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ERAS

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $732,800 40,000
2026-06-30 $732,800 40,000
2026-06-30 $13,071,942 713,534
2026-03-31 $794,598 49,110
2025-12-31 $356,264 95,770
2025-09-30 $33,235 15,246
2025-06-30 $90,688 71,409
2025-03-31 $208,553 152,229
2024-12-31 $607,328 241,964
2024-09-30 $366,821 134,367
2024-06-30 $114,933 48,701
2024-03-31 $32,518 15,786
2023-12-31 $30,305 14,228
2023-09-30 $4,070 2,066
2023-06-30 $100,466 36,401
2023-03-31 $9,929 3,299
2022-12-31 $550,628 127,756
2022-09-30 $645,559 82,764
2022-06-30 $41,697 7,486
2022-03-31 $59,056 6,867
2021-12-31 $149,271 9,581
2021-09-30 $50,015 2,357